Search

Displaying results 9731 - 9740 of 10000 in total
  1. Drug

    Robalzotan

    go.drugbank.com/drugs/DB06538
    Experimental

  2. Drug

    Nemonoxacin

    go.drugbank.com/drugs/DB06600
    Investigational

  3. Drug

    Almorexant

    go.drugbank.com/drugs/DB06673
    Investigational

  4. Drug

    Naluzotan

    go.drugbank.com/drugs/DB05562
    Investigational

  5. Drug

    Opebacan

    go.drugbank.com/drugs/DB06161
    Investigational

  6. Drug

    Maridebart Cafraglutide

    go.drugbank.com/drugs/DB19339
    Investigational

    Maridebart Cafraglutide is under investigation in clinical trial NCT05669599 (Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity

    Synonyms: insulinotropic polypeptide receptor) [275-cysteine,295-cysteine,300-glycine,305-cysteine] (human γ1-chain), disulfide with human κ-chain, dimer, 275,275′-bis(thioether) with 7-37-glucagon-like peptide I
  7. Drug

    Nanrilkefusp alfa

    go.drugbank.com/drugs/DB17480
    Investigational

    Nanrilkefusp alfa is a human fusion protein consisting of the cytokine interleukin (IL)-15 and the high-affinity binding sushi+ domain of IL-15 receptor alpha (IL-15Ra).

  8. Drug

    Meclinertant

    go.drugbank.com/drugs/DB06455
    Investigational

  9. Drug

    3-Methyl-5-(7-{4-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]phenoxy}heptyl)-1,2-oxazole

    go.drugbank.com/drugs/DB08727
    Experimental

    These are aromatic compounds containing an ether group substituted with a benzene ring. 3-Methyl-5-(7-{4-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]phenoxy}heptyl)-1,2-oxazole is known to target genome … 3-Methyl-5-(7-{4-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]phenoxy}heptyl)-1,2-oxazole is a solid. This compound belongs to the phenol ethers.

  10. Drug

    Safimaltib

    go.drugbank.com/drugs/DB21528
    Investigational

    Safimaltib is a small molecule drug. Safimaltib is under investigation in clinical trial NCT06788509 (A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring).